AI assistant
PULSE BIOSCIENCES, INC. — Director's Dealing 2017
Jun 9, 2017
32093_dirs_2017-06-09_49d4647c-9d07-4a69-9df3-77eb021a2bc1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-06-07
Reporting Person: UECKER DARRIN (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-07 | Common Stock | A | 160974 | $0.00 | Acquired | 160974 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-07 | Stock Option (right to buy) | $30.99 | A | 187286 | Acquired | 2027-06-07 | Common Stock (187286) | Direct |
| 2017-06-07 | Stock Option (right to buy) | $30.99 | A | 195000 | Acquired | 2027-06-07 | Common Stock (195000) | Direct |
Footnotes
F1: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will fully vest on June 1, 2018, subject to the Reporting Person's continued service as of that date.
F2: The shares subject to the option will vest in equal monthly installments over a four year period that began on June 21, 2016, subject to the Reporting Person's continued service through each vesting date.
F3: The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date.